Kevin M. Webb reports 5.61% stake in Accendra Health (NASDAQ: ACH)

Rhea-AI Filing Summary

Accendra Health, Inc. Schedule 13G: Kevin M. Webb reports beneficial ownership of 4,287,431 shares of Common Stock, representing 5.61% of the class as of 03/12/2026. The filing states Mr. Webb has sole voting power and sole dispositive power over all 4,287,431 shares.

The submission lists the issuer address as 10900 Nuckols Road, Suite 400, Glen Allen, Virginia, and is signed by Kevin M. Webb on 03/30/2026.

Insights

Corporate Governance Analyst

Insider stake disclosure: a passive holding above 5% that requires public reporting.

The filing shows 4,287,431 shares (5.61%) beneficially owned by Kevin M. Webb, with sole voting and sole dispositive power. Holdings above 5% trigger Schedule 13G/13D reporting thresholds and inform shareholder registry and disclosure records.

Because the form is a Schedule 13G-type disclosure, this indicates a reporting position rather than an announced acquisition strategy; subsequent filings could show any change in intent or ownership.

Market Structure Specialist

A 5.61% stake can be meaningful to float and potential block-trade considerations.

The position size—4,287,431 shares—represents a visible ownership slice that market participants may note when assessing free float and potential large-lot trading impact. The filing records sole dispositive authority, which centralizes decision-making over transfers or sales.

Any future sales or Schedule 13D amendments would materially change public disclosure and could affect trading interest; timing and intent are not stated here.

Key Figures

Shares beneficially owned: 4,287,431 shares Percent of class: 5.61% Reporting date: 03/12/2026 +2 more

5 metrics

Shares beneficially owned 4,287,431 shares Beneficial ownership reported

Percent of class 5.61% Percent of common stock as reported

Reporting date 03/12/2026 Date shown on the filing header

Signature date 03/30/2026 Filing signed by Kevin M. Webb

Voting power (sole) 4,287,431 shares Sole power to vote or direct the vote

Key Terms

Schedule 13G, Beneficially owned, Sole dispositive power

3 terms

Schedule 13G regulatory

"Schedule 13G reporting beneficial ownership above 5%"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Amount beneficially owned: 4,287,431 shares"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole dispositive power financial

"Sole power to dispose or to direct the disposition of: 4,287,431 shares"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Accendra Health, Inc.

(Name of Issuer)

Common Stock, par value $2 per share

(Title of Class of Securities)

690732102

(CUSIP Number)

03/12/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 690732102

1

Names of Reporting Persons

Kevin M. Webb

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,287,431.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,287,431.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,287,431.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.61 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Accendra Health, Inc.
(b)	Address of issuer's principal executive offices: 10900 Nuckols Road, Suite 400, Glen Allen, Virginia 23060
Item 2.
(a)	Name of person filing: Kevin M. Webb
(b)	Address or principal business office or, if none, residence: 7817 Ivanhoe Ave., Suite 100, La Jolla, CA 92037
(c)	Citizenship: United States of America
(d)	Title of class of securities: Common Stock, par value $2 per share
(e)	CUSIP Number(s): 690732102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Amount beneficially owned: 4,287,431 shares
(b)	Percent of class: Percent of class: 5.61%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,287,431 shares
	(ii) Shared power to vote or to direct the vote: 0 shares
	(iii) Sole power to dispose or to direct the disposition of: 4,287,431 shares
	(iv) Shared power to dispose or to direct the disposition of: 0 shares
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Kevin M. Webb

Signature:	/s/ Kevin M. Webb
Name/Title:	Kevin M. Webb
Date:	03/30/2026

FAQ

What stake does Kevin M. Webb hold in Accendra Health (ACH)?

Kevin M. Webb beneficially owns 4,287,431 shares, equal to 5.61% of Accendra Health's common stock as reported on 03/12/2026. The filing states he holds sole voting and sole dispositive power over these shares.

What does Schedule 13G mean for Accendra Health (ACH)?

Schedule 13G is a public disclosure of beneficial ownership by a shareholder holding >5%. It notifies the market that Kevin M. Webb holds 5.61% and documents his voting and dispositive authority over those shares.

Does the filing state whether Mr. Webb plans to sell or buy more shares?

The filing discloses ownership and control but does not state any intent to buy or sell. It only reports that Mr. Webb has sole voting and dispositive power over 4,287,431 shares as of 03/12/2026.

When was the Schedule 13G for ACH signed and by whom?

The Schedule 13G is signed by Kevin M. Webb and dated 03/30/2026. The ownership snapshot in the filing is tied to the 03/12/2026 date shown in the filing header.